Latest CSL News | Page 2

Target for imaging could improve detection of blood clots
Resistance-fighting antimalarial drug candidate enters the clinic
Prestigious Snow Medical Fellowship for Dr Michelle Boyle
Devonport collision highlights importance of bridge resource management
Starpharma announces appointment of chief financial officer
Australian Cell and Gene Catalyst takes step forward
CSL reports positive results from pivotal late-stage trial of first-in-class garadacimab
Houstonians’ input on study for trauma patient who are ‘bleeding out’
Europe approves CSL’s first gene therapy for Haemophilia B
Key franchise delivers for CSL as plasma collections top pre-pandemic levels
WA Government collaboration with Brandon BioCatalyst set to continue
Positive CHMP Opinion Etranacogene Dezaparvovec
CSL announces appointment of its new CEO and managing director
CSL Announces Next CEO & Managing Director
CSL Closing of Arcturus Therapeutics Agreement
CSL’s Novel Gene Therapy HEMGENIX Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living
CSL opens its new ‘Australian Plasma Fractionation Facility’ in Melbourne
New Australian Plasma Fractionation Facility
WEHI scientist recognised with CSL Florey Medal for malaria research
Debunking autism myths rewarded with national prize
Why autistic children are more likely to have gut problems
Lifetime investigating malaria leads to drugs that push back on resistance… And CSL Florey Medal
CSL secures US approval for breakthrough one-time haemophilia gene therapy
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
New AusBiotech Board fit for era
Cicada Innovations to operate new biotech incubator to drive translation of world class medical research
CSL R and D Day 2022
Cicada to operate new biotech incubator
CSL Enters Licensing Agreement
CSL and Translational Sciences enter Agreement
New HQ Earns Sustainability Credentials
Dr Michelle Boyle named 2023 CSL Centenary Fellow
Fighting malaria and chronic bowel disease: $2.5 million CSL Centenary Fellowships awarded
2023 CSL Centenary Fellowships awarded
Pollen does more than make you sneeze
CSL announces seven recipients of ‘Global Research Acceleration Initiative’ awards
CSL RAI Awardees Announced
Bernadette Murdoch to lead CSL’s Reputation CoE
CSL presents new research and development center in Marburg, Germany
AusBiotech 2022 programme launched
CSL grant delivers big support for Hume not-for-profit
CSL starts planning to submit new antibody treatment
Academy archive digitisation project boosted by generous donation
CSL Announces Positive Results for Garadacimab
CSL Announces Carbon Targets
CSL launches new brand identity
AusBiotech 2022 programme features top industry experts
Australia’s Cell and Gene Catalyst moves ahead